Alaska’s addiction crisis demands swift action, yet a decades‑old regulatory hurdle is slowing progress. The state’s Certificate of Need (CON) program requires approval before a new health‑care facility can be built or expanded, and it gives existing providers a formal legal avenue to object. In practice, this turns market entry into costly litigation, delaying much‑needed treatment capacity.

How CON Works and Why It Stalls Care

Under Alaska Statute 18.07.031, any provider seeking to spend more than $1.5 million on a new facility, expansion, or major equipment must obtain a CON. The program, adopted in 1976, was originally tied to federal health‑planning funds that have since been repealed. While many states have abandoned CON, Alaska retained it for behavioral‑health facilities, psychiatric hospitals, and residential treatment centers.

The key feature is that existing providers can formally object, arguing that the state should avoid “unnecessary duplication” of services. This legal right often leads to protracted hearings and appeals, diverting resources from patient care to lawyers and consultants.

Fairbanks Case Shows the Cost

A 2006‑2007 Fairbanks dispute illustrates the impact. Two physician‑owned companies, Kobuk Ventures LLC and Alaska Medical Development‑Fairbanks LLC, applied for certificates to open ambulatory surgery centers. Fairbanks Memorial Hospital, the sole existing provider, filed a competing application and appealed the new certificates. The administrative case lasted roughly twenty months, involved about fifty hours of testimony, and generated a 1,600‑page record. A staff error that inflated projected need by nearly 21 % was not corrected until late in the process. When the commissioner finally ruled in 2007, the new providers received their certificates, but only after two years of costly delays.

Similar competitor‑veto battles have occurred in Kenai and Anchorage, where incumbents used CON objections to block or delay new facilities even after construction was complete.

When CON Works – And When It Doesn’t

CON does not block every new project. In 2026, Providence Health and Services secured approval for a sixteen‑bed youth residential psychiatric facility in Anchorage, and Mat‑Su Regional Medical Center’s forty‑five‑bed behavioral‑health hospital in Palmer moved through CON review without objection. In both cases, the applicants were already the dominant providers in their markets, leaving no incumbent with standing to object.

The pattern is clear: CON approval proceeds smoothly for incumbents, but independent or new‑entrant providers—exactly the type of operators needed to expand capacity quickly—face lengthy, adversarial battles.

The Bigger Addiction Gap

Federal survey data shows the scale of the problem. In 2022‑2023, an estimated 131,000 Alaskans age 12 and older needed substance‑use treatment, yet roughly 101,000 (nearly 79 %) received no care at all. Fentanyl was involved in 73 % of overdose deaths in 2024, and methamphetamine was present in over half of fatal overdoses between 2017‑2023, often alongside opioids.

Even with new capacity slated to open in the coming years, the unmet need dwarfs current plans. The shortage is not primarily a funding issue—Alaska channels tens of millions of dollars annually through Medicaid, the opioid settlement fund, and the Alaska Mental Health Trust—but a structural one rooted in regulation.

Proposed Reforms

The analysis recommends a five‑part reform framework:

• A targeted CON exemption for behavioral‑health facilities that meet certain criteria, allowing faster entry for new providers.
• Conditional tax relief for any provider—whether for‑profit or nonprofit—that adds licensed treatment capacity and accepts Medicaid patients.
• A statutory conflict‑of‑interest bar for the Alaska Advisory Board on Alcoholism and Drug Abuse (ABADA), modeled after the conflict‑of‑interest rules already applied to the Mental Health Trust Authority’s board.
• A state resolution urging Alaska’s congressional delegation to address the federal Medicaid Institutions for Mental Diseases (IMD) exclusion that caps reimbursement for adult residential treatment at 16 beds.
• Medicaid rate reforms recommended by the state’s contracted rate consultant to improve reimbursement for providers.

Implementing these changes could remove barriers, reduce litigation costs, and expand treatment capacity for the thousands of Alaskans currently left without help.

Original reporting: Must Read Alaska (Anchorage) — read the source article.